Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 339 results for "sll"

IIROC Trade Resumption / L'OCRCVM permet la reprise de la nego...

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 1, 2016) - Trading resumes in / Reprise des negociations pour : ---------------------------------------------------------------------------- Company / Societe : STANDARD LITHIUM LTD. ... Benzinga.com, 1 month ago
[x]  

31 images for sll

Before It's News, 1 week ago
Before It's News, 1 week ago
Cancer Therapy Advisor, 4 days ago
Before It's News, 2 weeks ago
Before It's News, 2 weeks ago
Before It's News, 3 weeks ago
Before It's News, 1 month ago
Targeted Oncology, 1 month ago
EuroInvestor, 1 month ago
Before It's News, 1 month ago
EuroInvestor

MorphoSys begins COSMOS phase 2 trial of MOR208 in combo with idelalisib in patients with relapsed/refractory CLL or SLL

MorphoSys AG announced that the first patient was dosed in a phase 2 combination trial of MOR208 with idelalisib (Zydelig). The trial, which has been named COSMOS (CLL patients assessed for ORR & Safety in MOR208 Study), is designed to evaluate the ...
 PharmaBiz1 month ago MorphoSys begins Phase II COSMOS trial of MOR208 combined with idelalisib to treat CLL or SLL  Drug Development Technology1 month ago MorphoSys Starts Phase 2 Trial of MOR208 in Combination with Idelalisib in Patients with Relapsed or Refractory CLL or SLL Previously Treated with a BTK Inhibitor  SPi World News1 month ago MorphoSys AG Starts Phase 2 Trial Of MOR208 In Combination With Idelalisib In Patients With Relapsed Or Refractory CLL Or SLL Previously Treated With A BTK Inhibitor  BioSpace1 month ago
[x]  
Reuters UK

Britain's FTSE posts highest close since October

* FTSE 100 up 1.1 pct * Miners drop ahead of Fed rate decision * Standard Life (LSE: SL.L - news ) falls after downgrade (ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see ...
 Yahoo! Finance UK and Ireland1 month ago FTSE edges higher though miners drop  Yahoo! UK and Ireland1 month ago Britain's FTSE edges higher though miners drop  Yahoo! Finance UK and Ireland1 month ago

IIROC Trading Resumption - SLL, VHI

VANCOUVER, Dec. 1, 2016 /CNW/ - Trading resumes in: Company: STANDARD LITHIUM LTD. TSX-Venture Symbol: SLL Formerly : PATRIOT PETROLEUM CORP. ("PPC") Resumption (ET): 8:00 AM Dec. 2, 2016 Company: VITALHUB CORP. TSX-Venture Symbol: VHI ...
 Yahoo! Finance1 month ago IIROC Trade Resumption - Standard Lithium Ltd.  Newsfile1 month ago
[x]  
Cancer Therapy Advisor

IMBRUVICA® (ibrutinib) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5-Year Analysis and Long-Term RESONATE-2 Follow-up Data at ASH 2016 Show Lasting Efficacy

- Nearly nine out of 10 patients (89%) with CLL/SLL achieve complete or partial response at five-year analysis - Longest follow-up to-date shows disease control and improving responses with extended single-agent ibrutinib therapy in first and ...
 PR Newswire1 month ago Sentinel case of Richter transformation from chronic lymphocytic leukaemia/small lymphocytic lymphoma to CD3+ diffuse large B-cell lymphoma  Journal of Clinical Pathology1 month ago Venetoclax Plus Rituximab Promising for Relapsed/Refractory CLL  Cancer Therapy Advisor3 days ago IMBRUVICA ibrutinib Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5-Year Analysis and Long-Term RESONATE-2 Follow-up Data at ASH 2016 Show...  Pharmacy Choice3 weeks ago
[x]  

'Why did Standard Life stop sending us statements for our £250k savings?'

My financial adviser introduced me and my wife to a Standard Life (LSE: SL.L - news ) capital investment bond, which we took out in January 2008. We paid in £150,000 then and added a further £100,000 in July 2011. This provides us with an ...
 Yahoo! Finance UK and Ireland1 month ago

Standard Lithium Ltd. Announces Closing of $5.0 Million Private Placement

/ (TSX-V: SLL) . (Standard Lithium or the Company) is pleased to report that it has closed its previously announced non-brokered private placement (the Private Placement) for gross proceeds of $5.0 million. An aggregate of 20,000,600 common ...
 SSUChronicle.com3 days ago STANDARD LITHIUM LTD (SLL)  INO.com1 month ago Standard Lithium Ltd. Enters into LOI to Acquire Moab Minerals Corp.  Yahoo! Finance1 month ago
[x]  

BGB-3111 Demonstrates Nearly 100% Response Rate in CLL/SLL

Constantine S. Tam, MBBS Treatment with the BTK inhibitor BGB-3111 had an objective response rate (ORR) of 96% for patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), according to findings from a phase I study ...
 Targeted Oncology1 month ago BRIEF-Beigene presents updated clinical data on BTK Inhibitor BGB-3111 in CLL, SLL patients  Reuters UK1 month ago BeiGene Presents Updated Clinical Data on BTK Inhibitor BGB-3111 in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia at the 2016 American Society of Hematology Annual Meeting  Nasdaq1 month ago
[x]  
Cancer Therapy Advisor

Single-agent Ibrutinib Therapy Provides Durable Response in CLL/SLL

Share this content: Treatment with single-agent ibrutinib was well-tolerated in chronic lymphocytic leukemia/small lymphocytic lymphoma. Treatment with single-agent ibrutinib was well-tolerated and provided durable responses among patients with ...
 Cancer Therapy Advisor4 days ago Ibrutinib continues to wow in CLL/SLL  PM 3605 days ago RESONATE-2 Continues to Impress With Single-Agent Ibrutinib for CLL/SLL at 29 Months  American Journal of Managed Care1 month ago Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma  Clinical Cancer Research6 days ago

MEDTRONIC : ADDvise receives frame agreement from SLL at an order value of 20 + 20 MSEK

IM-Medico Svenska AB, a subsidiary in the ADDvise Group, has been awarded a frame agreement for laparoscopy products from the County Council of Stockholm. The estimated value of the agreement for IM-Medico is 10 MSEK per annum. The agreement runs ...
 4 Traders6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less